These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 14435089)

  • 1. [Remote clinical results in patients with prostatic carcinoma treated with hexestrol diphosphate].
    PROSPERI F
    Minerva Urol; 1959; 11():295-307. PubMed ID: 14435089
    [No Abstract]   [Full Text] [Related]  

  • 2. [Study of blood acid phosphatases in the therapy of carcinoma of the prostate with hexestrol diphosphate by the rectal route].
    MARINI A
    Boll Soc Med Chir Cremona; 1960; 14():53-64. PubMed ID: 13766812
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapy of carcinoma of the prostate with hexestrol diphosphate administered by rectal route].
    FRANCH L; TERRUZZI B
    Boll Soc Med Chir Cremona; 1960; 14():67-74. PubMed ID: 13701208
    [No Abstract]   [Full Text] [Related]  

  • 4. Alternation of estrogen therapy in advanced carcinoma of the prostate.
    DESBERG D
    J Urol; 1960 Apr; 83():463-7. PubMed ID: 13816097
    [No Abstract]   [Full Text] [Related]  

  • 5. Endocrine therapy in carcinoma of the prostate gland: 10-year survival studies.
    EMMETT JL; GREENE LF; PAPANTONIOU A
    J Urol; 1960 Apr; 83():471-84. PubMed ID: 13820205
    [No Abstract]   [Full Text] [Related]  

  • 6. The oral use of hexestrol for estrogen deficiency.
    HARDING FE
    Am J Obstet Gynecol; 1946 May; 51():660-5. PubMed ID: 21025149
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of stilbestrol on the testis and breast of patients treated for carcinoma of the prostate gland.
    SCHWARTZ M
    Rocky Mt Med J; 1946 Aug; 43():643. PubMed ID: 20994492
    [No Abstract]   [Full Text] [Related]  

  • 8. Carcinoma of prostate treated with oestrogens.
    FERGUSSON JD
    Lancet; 1946 Oct; 2(6425):551-6. PubMed ID: 21001706
    [No Abstract]   [Full Text] [Related]  

  • 9. [15 years of experience in the treatment of prostatic carcinoma with estrogens].
    LE CLERC-DANDOY V
    Acta Urol Belg; 1960 Oct; 28():514-7. PubMed ID: 13759824
    [No Abstract]   [Full Text] [Related]  

  • 10. The therapeutic effect of concurrent administration of 5-fluorouracil and allylestrenol or hexestrol in small doses on prostatic carcinoma.
    Takeuchi H
    Prostate Suppl; 1981; 1():111-7. PubMed ID: 6281750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effectiveness of 5-fluorouracil combined with hormones in low dose as a basal treatment for prostatic carcinoma].
    Takeuchi H
    Hinyokika Kiyo; 1984 Nov; 30(11):1703-9. PubMed ID: 6099050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Possibilities of hormone therapy in osseous metastases of prostatic carcinoma in elderly subjects].
    SEBASTIANI C
    G Gerontol; 1960 Jul; 8():475-83. PubMed ID: 13749524
    [No Abstract]   [Full Text] [Related]  

  • 13. Gastric dysfunction of hypoestrogenic origin; treatment with benzestrol.
    HUFFORD AR
    J Clin Endocrinol Metab; 1946 Dec; 6(6):817-22. PubMed ID: 20288022
    [No Abstract]   [Full Text] [Related]  

  • 14. Carcinoma of the prostate; a résumé of treatment with ethinyl estradiol; preliminary report.
    McCREA LE
    J Urol; 1946 Dec; 56(6):697-703. PubMed ID: 20279550
    [No Abstract]   [Full Text] [Related]  

  • 15. [CONTRIBUTION TO THE TREATMENT OF CANCER OF THE PROSTATE].
    FRIGNANI L
    Riv Patol Clin; 1963 Dec; 18():779-85. PubMed ID: 14158414
    [No Abstract]   [Full Text] [Related]  

  • 16. [FEMALE SEX HORMONE THERAPY FOR PROSTATIC HYPERTROPHY].
    WANG IK; LIU Y; LI TC
    Zhonghua Wai Ke Za Zhi; 1964 Mar; 12():295-9. PubMed ID: 14173091
    [No Abstract]   [Full Text] [Related]  

  • 17. [Morphology of prostatic adenoma and its relation to sinestrol therapy].
    LAPIN AA
    Urol Mosc; 1956; 21(2):19-25. PubMed ID: 13352592
    [No Abstract]   [Full Text] [Related]  

  • 18. [Carcinoma prostatae with skeletal metastases, treated with estrogenic substances].
    GROEN J
    Ned Tijdschr Geneeskd; 1948 Oct; 92(42):3292-8. PubMed ID: 18099264
    [No Abstract]   [Full Text] [Related]  

  • 19. [Nearly 10 years survival of metastizing prostatic carcinoma treated systematically with estrogens].
    PRINCI P; SCALETTA S
    Riforma Med; 1961 Feb; 75():161-4. PubMed ID: 13738047
    [No Abstract]   [Full Text] [Related]  

  • 20. [Histological changes in prostatic carcinoma caused by therapy with combined natural estrogens].
    FABRIS P; COPPI F
    Arch Ital Urol; 1960 Dec; 33():345-54. PubMed ID: 13697831
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.